Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2000 2024

• 4 Active
• 5 Finished

Projects per year

A Randomized, multi-center, Phase 3 Study of Nivolumab in Combination with Ipilimumab Compared to Sorafenib or Lenvatinib as First-Line Treatment in Participants with Advances Hepatocellular Carcinoma

Dev, A.

4/10/19 → 3/10/24

Project: Research

A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of Durvalumab Monotherapy or in Combination With Bevacizumab as Adjuvant Therapy in Patients With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation (EMERALD-2)

Dev, A.

26/07/19 → 25/07/24

Project: Research

A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Transarterial Chemoembolization (TACE) in Combination with either Durvalumab Monotherapy or Durvalumab plus Bevacizumab Therapy in Patients with Locoregional Hepatocellular Carcinoma

Dev, A.

11/03/19 → 10/03/24

Project: Research

An Open-Label, Multicenter Phase IB Study of the Safety and Efficacy of Atezolizu-L1 Antibody) Administered in Combination with Bevacizumab and/or Other Treatments in Patients with Solid Tumors (G030140) – Arm F Only

Dev, A.

16/11/18 → 15/11/22

Project: Research

Southern Health Hepatitis B Patient Disease Knowledge

Dev, A.

Bristol-Myers Squibb Australia

1/06/13 → 31/05/14

Project: Research

Research Output 2002 2020

• 29 Article
• 1 Commissioned Report
• 1 Letter

Research Output per year

Survival of patients with ruptured and non-ruptured hepatocellular carcinoma

Tan, N. P., Majeed, A., Roberts, S. K., Gow, P. J., Hey, P., Mah, X., Goodwin, M., Sood, S., Lubel, J., Nicoll, A., Dev, A., Bell, S. J. & Kemp, W. W., 25 Jan 2020, (Accepted/In press) In : Medical Journal of Australia. 2 p.

Research output: Contribution to journal › Letter › Other › peer-review

1 Citation (Scopus)

Immunomodulator use does not prevent first loss of response to anti-tumour necrosis factor alpha therapy in inflammatory bowel disease: long-term outcomes in a real-world cohort

Varma, P., Rajadurai, A., Holt, D. Q., Devonshire, D. A., Desmond, C., Swan, M. P., Nathan, D., Shelton, E., Prideaux, L., Sorrell, C., Rusli, F., Crantock, L. RF., Dev, A., Ratnam, D., Pianko, S. & Moore, G., 1 Jun 2019, In : Internal Medicine Journal. 49, 6, p. 753-760 8 p.

Research output: Contribution to journal › Article › Research › peer-review

Australian recommendations for the management of hepatitis C virus infection: a consensus statement (September 2018)

Hepatitis C Virus Infection Consensus Statement Working Group, 2018, Melbourne VIC Australia: Gastroenterology Society of Australia. 71 p.

Research output: Book/Report › Commissioned Report › Other

Open Access

File

5 Citations (Scopus)

Barriers to Accessing Testing and Treatment for Chronic Hepatitis B in Afghan, Rohingyan, and South Sudanese Populations in Australia

Sievert, K., O’Neill, P., Koh, Y., Lee, J. H., Dev, A. & Le, S., Feb 2018, In : Journal of Immigrant and Minority Health. 20, 1, p. 140-146 7 p.

Research output: Contribution to journal › Article › Research › peer-review

4 Citations (Scopus)

Increased prevalence of fracture and hypoglycaemia in young adults with concomitant type 1 diabetes mellitus and coeliac disease

Thong, E. P., Wong, P., Dev, A., Ebeling, P. R., Teede, H. J. & Milat, F., 1 Jan 2018, In : Clinical Endocrinology. 88, 1, p. 37-43 7 p.

Research output: Contribution to journal › Article › Research › peer-review